The endocrinological basis of recurrent miscarriages

Area of Science:

• Reproductive Endocrinology
• Obstetrics and Gynecology

Background:

• Recurrent miscarriage (RM) affects a significant number of women.
• Endocrinological factors play a crucial role in early pregnancy establishment and maintenance.
• Advances in understanding endometrial function and hormonal signaling are key to improving outcomes.

Purpose of the Study:

• To review endocrinological aspects of recurrent miscarriage.
• To discuss recent advances in diagnosis and management.
• To highlight emerging areas of research in RM.

Main Methods:

• Literature review of studies published between January 2004 and January 2005.
• Analysis of diagnostic criteria for endometrial biopsy.
• Evaluation of evidence for progestogen use in preventing RM.
• Review of the role of endocannabinoids in implantation and pregnancy.

Main Results:

• Endometrial luteal phase defect is linked to recurrent miscarriage.
• The accuracy and clinical utility of endometrial biopsy dating were critically analyzed.
• Progestogen use demonstrated a statistically significant, albeit small, increase in live birth rates for RM.
• Endocannabinoids and fatty acid amide hydrolase show potential roles in implantation and pregnancy maintenance.

Conclusions:

• Abnormal secretory endometrial changes can negatively impact early pregnancy outcomes.
• Biochemical and molecular markers may offer improved endometrial dating and outcome prediction.
• Further large-scale randomized controlled trials are needed to confirm the efficacy of progestogens (with or without estrogens) for RM prevention.
• The role of endocannabinoids and their receptor modulators presents a promising avenue for future research in RM.